Related Experiment Videos
A common Japanese haplotype HLA-A26-Cw3-B61-DR9-DQ3 carries HLA-B*4002
L Ling1, Y Watanabe, K Tokunaga
1Department of Transfusion Medicine and Immunohematology, Faculty of Medicine, University of Tokyo, Japan.
Tissue Antigens
|November 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Modulation of apolipoprotein gene expression in fatty liver of obese rats: enhanced APOA-IV, but no APOB expression by a high sucrose diet.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·1997
Early morphologic changes of atherosclerosis induced by ventromedial hypothalamic lesion in the spontaneously diabetic Goto-Kakizaki rat.
The Journal of laboratory and clinical medicine·1997
Linkage-disequilibrium mapping narrows the Fukuyama-type congenital muscular dystrophy (FCMD) candidate region to <100 kb.
American journal of human genetics·1996
Routine low and high resolution typing of the HLA-DRB gene using the PCR-MPH (microtitre plate hybridization) method.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics·1996
[Progress of DNA based HLA typing methods].
Nihon rinsho. Japanese journal of clinical medicine·1996
Questionable expression of unstable DQ heterodimer containing HLA-DQA1*01:07.
Tissue antigens·2015
Giant cardiac hemangioma: case report and literature review.
European heart journal. Case reports·2026
Integrated microarray-based and single-cell transcriptomic analyses reveal cell adhesion-related fibrotic remodeling signatures in heart failure.
Frontiers in molecular biosciences·2026
Development and validation of a machine learning model for predicting coronary artery disease risk: a retrospective study.
Frontiers in cardiovascular medicine·2026
A diagnostic and classification model integrating cTnI, CK-MB, MYO and NT-proBNP for cardiovascular diseases.
Experimental and therapeutic medicine·2026